Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Harrington

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Plos One|August 26, 2015
The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and RiskKimberly H Harrington, Chelsea J Gudgeon, George S Laszlo, et al.
Addictive Behaviors|August 22, 2016
Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugsDavid M Lydon-Staley, H Harrington Cleveland, Andrew S Huhn, et al.
Development and Psychopathology|February 3, 2015
The conditioning of intervention effects on early adolescent alcohol use by maternal involvement and dopamine receptor D4 (DRD4) and serotonin transporter linked polymorphic region (5-HTTLPR) genetic variantsH Harrington Cleveland, Gabriel L Schlomer, David J Vandenbergh, et al.
Child Development|November 19, 2016
Extending Previous cG×I Findings on 5-HTTLPR's Moderation of Intervention Effects on Adolescent Substance Misuse InitiationGabriel L Schlomer, H Harrington Cleveland, Mark E Feinberg, et al.
Blood|December 7, 2013
Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AMLGeorge S Laszlo, Chelsea J Gudgeon, Kimberly H Harrington, et al.
Leukemia & Lymphoma|June 12, 2012
High expression of neutrophil elastase predicts improved survival in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupChelsea J Gudgeon, Kimberly H Harrington, George S Laszlo, et al.
Oncotarget|June 2, 2016
Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemiaGeorge S Laszlo, Kimberly H Harrington, Chelsea J Gudgeon, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 6, 2015
An Adolescent Substance Prevention Model Blocks the Effect of CHRNA5 Genotype on Smoking During High SchoolDavid J Vandenbergh, Gabriel L Schlomer, H Harrington Cleveland, et al.
Leukemia|April 12, 2014
Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemiaR B Walter, G S Laszlo, J M Lionberger, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|February 3, 2017
Transactions Between Substance Use Intervention, the Oxytocin Receptor (OXTR) Gene, and Peer Substance Use Predicting Youth Alcohol UseH Harrington Cleveland, Amanda M Griffin, Pedro S A Wolf, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Plos One|August 26, 2015
The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and RiskKimberly H Harrington, Chelsea J Gudgeon, George S Laszlo, et al.
Addictive Behaviors|August 22, 2016
Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugsDavid M Lydon-Staley, H Harrington Cleveland, Andrew S Huhn, et al.
Development and Psychopathology|February 3, 2015
The conditioning of intervention effects on early adolescent alcohol use by maternal involvement and dopamine receptor D4 (DRD4) and serotonin transporter linked polymorphic region (5-HTTLPR) genetic variantsH Harrington Cleveland, Gabriel L Schlomer, David J Vandenbergh, et al.
Child Development|November 19, 2016
Extending Previous cG×I Findings on 5-HTTLPR's Moderation of Intervention Effects on Adolescent Substance Misuse InitiationGabriel L Schlomer, H Harrington Cleveland, Mark E Feinberg, et al.
Blood|December 7, 2013
Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AMLGeorge S Laszlo, Chelsea J Gudgeon, Kimberly H Harrington, et al.
Leukemia & Lymphoma|June 12, 2012
High expression of neutrophil elastase predicts improved survival in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupChelsea J Gudgeon, Kimberly H Harrington, George S Laszlo, et al.
Oncotarget|June 2, 2016
Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemiaGeorge S Laszlo, Kimberly H Harrington, Chelsea J Gudgeon, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 6, 2015
An Adolescent Substance Prevention Model Blocks the Effect of CHRNA5 Genotype on Smoking During High SchoolDavid J Vandenbergh, Gabriel L Schlomer, H Harrington Cleveland, et al.
Leukemia|April 12, 2014
Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemiaR B Walter, G S Laszlo, J M Lionberger, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|February 3, 2017
Transactions Between Substance Use Intervention, the Oxytocin Receptor (OXTR) Gene, and Peer Substance Use Predicting Youth Alcohol UseH Harrington Cleveland, Amanda M Griffin, Pedro S A Wolf, et al.
Pageof 12